CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...

When Sarah told her elderly mother about what she had found, she was horrified to hear that James had also been sexually ...

The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article ...

London: GSK plc has received approval for Blenrep in the European Union (EU) for the treatment of adults with relapsed or ...

The combinations are also approved for relapsed or refractory multiple myeloma in Japan, the UK and other markets including ...

GSK (GSK) stock in focus as the company secures EU approval for Blenrep combo therapies targeting the blood cancer multiple ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

The question isn’t, “will you use AI?” The question is, “what kind of AI user do you want to be: driver or passenger?” ...

GSK’s share price has fallen a lot in 10 months, which means it could be a huge bargain. I ran the key numbers and examined ...